Literature DB >> 16803489

Outcomes of loop electrosurgical excision procedure for cervical neoplasia in human immunodeficiency virus-infected women.

C Kietpeerakool1, J Srisomboon, P Suprasert, C Phongnarisorn, K Charoenkwan, C Cheewakriangkrai, S Siriaree, C Tantipalakorn, A Pantusart.   

Abstract

The objective of this study was to evaluate the treatment outcomes and complications in human immunodeficiency virus (HIV)-infected women undergoing loop electrosurgical excision procedure (LEEP) for cervical neoplasia. The medical record of 60 evaluable HIV-infected women who had abnormal Papanicolaou (Pap) smear and underwent LEEP following colposcopy at Chiang Mai University Hospital between May 1998 and June 2004 was reviewed. Thirty-one (51.7%) had associated genital infection at screening. Twenty-five (41.7%) had opportunistic infection, but only 18 (30.0%) were treated with antiretroviral therapy. The most common abnormal Pap smear was high-grade squamous intraepithelial lesion (46.7%), followed by low-grade squamous intraepithelial lesion (40.0%). Forty (66.7%) women had clear surgical margins after LEEP. Only one (1.7%) woman had severe intraoperative hemorrhage. Early and late postoperative hemorrhage were noted in three (5%) women of each period. Localized infection of the cervix was detected in seven (11.7%) women. Two (3.3%) women developed cervical stenosis at 6 months after LEEP. There was no significant difference in overall complications between HIV-infected women and the control group (P= 0.24). Among 60 HIV-infected women, no statistical difference in the rate of margins involvement (P= 1.00) and complications (P= 0.85) could be demonstrated between HIV-infected women who received antiretroviral therapy and those who did not. Disease-free rate at 6 and 12 months were 97.1% and 88%, respectively. These data demonstrated that LEEP appears to be safe and effective in HIV-infected women.

Entities:  

Mesh:

Year:  2006        PMID: 16803489     DOI: 10.1111/j.1525-1438.2006.00518.x

Source DB:  PubMed          Journal:  Int J Gynecol Cancer        ISSN: 1048-891X            Impact factor:   3.437


  6 in total

Review 1.  Are treatments for cervical precancerous lesions in less-developed countries safe enough to promote scaling-up of cervical screening programs? A systematic review.

Authors:  Eric Chamot; Sibylle Kristensen; Jeffrey S A Stringer; Mulindi H Mwanahamuntu
Journal:  BMC Womens Health       Date:  2010-04-01       Impact factor: 2.809

2.  Cervical surgery for cervical intraepithelial neoplasia and prolonged time to conception of a live birth: a case-control study.

Authors:  C N Spracklen; K K Harland; B J Stegmann; A F Saftlas
Journal:  BJOG       Date:  2013-03-14       Impact factor: 6.531

3.  Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field.

Authors:  Krista S Pfaendler; Mulindi H Mwanahamuntu; Vikrant V Sahasrabuddhe; Victor Mudenda; Jeffrey S A Stringer; Groesbeck P Parham
Journal:  Gynecol Oncol       Date:  2008-06-16       Impact factor: 5.482

Review 4.  Treatment of pre- and confirmed cervical cancer in HIV-seropositive women from developing countries: a systematic review.

Authors:  Witness Mapanga; Elvira Singh; Shingairai A Feresu; Brendan Girdler-Brown
Journal:  Syst Rev       Date:  2020-04-10

5.  Bolstering the Evidence Base for Integrating Abortion and HIV Care: A Literature Review.

Authors:  Ruth Manski; Amanda Dennis; Kelly Blanchard; Naomi Lince; Dan Grossman
Journal:  AIDS Res Treat       Date:  2012-12-18

6.  Residual or Recurrent Precancerous Lesions After Treatment of Cervical Lesions in Human Immunodeficiency Virus-infected Women: A Systematic Review and Meta-analysis of Treatment Failure.

Authors:  Pierre Debeaudrap; Joelle Sobngwi; Pierre-Marie Tebeu; Gary M Clifford
Journal:  Clin Infect Dis       Date:  2019-10-15       Impact factor: 9.079

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.